Spekle Solutions specializes in shaping market access and commercial strategies for life sciences. The company uses advanced analytical techniques and technology to provide customized solutions and insights.

Spekle Solutions

Watchmaker Genomics develops high-performance next-generation sequencing products for various applications including inherited disease and somatic oncology, rare variant detection, ctDNA analysis, transcriptomics, epigenetics, and single-cell assays.

Watchmaker Genomics

CMB Genomics provides clinical diagnostic testing, next generation sequencing, and laboratory genetic testing services. It focuses on enhancing access to molecular diagnostics in Africa through genetic testing and training.

CENTRE FOR MOLECULAR BIOSCIENCES AND GENOMICS LIMITED

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

Metric
Company Name	Spekle Solutions	Watchmaker Genomics	CENTRE FOR MOLECULAR BIOSCIENCES AND GENOMICS LIMITED
Symbol
MSH ID	COM:SPEKLESOLUTIONS	COM:WATCHMAKERGENOMICS	ORG:CMBGENOMICS
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Consulting	Biotechnology	Biotechnology
Country	US	US	KE
Stage
Employee Count
Website	speklesolutions.com	watchmakergenomics.com	cmbgenomics.org
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SINGULARGENOMICS

Singular Genomics

Last Close

21.40

22/11 21:00

Market Cap

53.80M

Beta: -

Volume Today

10.54K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue